Form 4 for SKYE Skye Bioscience, Inc.
Accepted 2024-08-27 00:00:00 ET · period of report 2024-08-26 · accession 0001516551-24-000078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-27 | 2024-08-26 | SKYE | DHILLON PUNIT | CEO, Dir | J - Other | — | +15.7K | 412.7K | +4% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-26 | J | A | 15,727 | — | 412,733 | D | — | — | (F1) Shares received by reporting person in connection with one of Issuer's shareholders pro rata distribution of common stock of Issuer to its shareholders. |